All In Biotech

Drug Trial Radar · NCT05509400

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

BHV3000-406 (C4951004): A Phase 4, Randomized, Double-blind Placebo-Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 813 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

813

Actual

Start

Oct 18, 2022

Primary completion

Mar 10, 2025

Study completion Jun 10, 2025

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Aug 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).

Conditions

  • Migraine

Interventions

  • RimegepantDrug

    DB Phase: Rimegepant 75 mg Orally Disintegrating Tablet (ODT)

  • PlaceboDrug

    DB Phase: matching placebo

  • RimegepantDrug

    OLE Phase: Rimegepant 75 mg ODT in association with each of the first 5 qualifying migraines

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Pain Relief at 2 Hours Post-Dose: DBT PhaseTime frame: At 2 hours post-dose

Locations

93 sites in 15 countries. Site status is shown where the registry gives one.

  • Clinical Research Institute

    Los Angeles, California

  • Ki Health Partners LLC, dba New England Institute for Clinical Research

    Stamford, Connecticut

  • Wr-Msra, Llc

    Lake City, Florida

  • Sensible Healthcare LLC

    Ocoee, Florida

  • Sandhill Research, LLC d/b/a Accel Research Sites Network - Ormond Clinical Research Unit

    Ormond Beach, Florida

  • WR-Mount Vernon Clinical Research, LLC

    Sandy Springs, Georgia

  • Collective Medical Research

    Overland Park, Kansas

  • DelRicht Research

    New Orleans, Louisiana

  • Boston Clinical Trials

    Boston, Massachusetts

  • Community Clinical Research Network Inc

    Marlborough, Massachusetts

  • Michigan Headache & Neurological Institute

    Ann Arbor, Michigan

  • Rochester Medical Group

    Rochester Hills, Michigan

  • DM Clinical Research - Detroit

    Southfield, Michigan

  • Clinvest Research, LLC

    Springfield, Missouri

  • St Charles Clinical Research

    Weldon Spring, Missouri

  • DM Clinical Research - NY, NY

    Brooklyn, New York

  • New York Neurology Associates

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Headache Wellness Center, PC

    Greensboro, North Carolina

  • Synexus Clinical Research US, Inc. - Anderson

    Anderson, South Carolina

  • Red Star Research, LLC

    Lake Jackson, Texas

  • DM Clinical Research

    Tomball, Texas

  • Northwest Clinical Research Center

    Bellevue, Washington

  • USC Clinical Trials Centre

    Sippy Downs, Queensland, Australia

  • Alfred Hospital

    Melbourne, Victoria, Australia

  • Klinikum Klagenfurt am Wörthersee

    Klagenfurt, Carinthia, Austria

  • Medical University Innsbruck

    Innsbruck, Tyrol, Austria

  • GZA Ziekenhuizen

    Antwerp, Belgium

  • UZ Brussel

    Brussels, Belgium

  • UZ Gent

    Ghent, Belgium

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • Cabinet Privé Dr. Simona Sava

    Saint-Nicolas, Liège, Belgium

  • ALPHA Recherche Clinique

    Québec, Canada

  • University of Calgary South Health Campus

    Calgary, Alberta, Canada

  • Aggarwal and Associates Limited

    Brampton, Ontario, Canada

  • Clinique Neuro-Lévis

    Lévis, Quebec, Canada

  • Alpha Recherche Clinique

    Québec, Quebec, Canada

  • University Hospital of Southern Denmark

    Esbjerg, Denmark

  • Danish Headache Center

    Glostrup Municipality, Denmark

  • Hospitalsenhed Midt

    Viborg, Denmark

Showing 40 of 93 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.